gamma scintillation counter (Revvity)
Revvity is a verified supplier 
Revvity manufactures this product 
96
Structured Review
Revvity
gamma scintillation counter
Gamma Scintillation Counter, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 3466 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gamma+scintillation+counter/Wizard2+Gamma+Counter/10__1007_slash_s12553___025___00975___7-54-30-35
Average 96 stars, based on 3466 article reviews
Gamma Scintillation Counter, supplied by Revvity, used in various techniques. Bioz Stars score: 96/100, based on 3466 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/gamma+scintillation+counter/Wizard2+Gamma+Counter/10__1007_slash_s12553___025___00975___7-54-30-35
Average 96 stars, based on 3466 article reviews
gamma scintillation counter - by Bioz Stars,
2026-09
96/100 stars
Images
Related Articles
Activity Assay:Article Title: Multifunctional Fluoropolymer-Engineered Magnetic Nanoparticles to Facilitate Blood-Brain Barrier Penetration and Effective Gene Silencing in Medulloblastoma. Article Snippet: .. Using a Article Title: Multifunctional Fluoropolymer‐Engineered Magnetic Nanoparticles to Facilitate Blood‐Brain Barrier Penetration and Effective Gene Silencing in Medulloblastoma Article Snippet: .. Using a Radioactivity:Article Title: Impact of overt and subclinical hepatogenous diabetes and metformin treatment on circulatory function, renal function and hemodynamics, inflammatory activity, and prognosis in patients with cirrhosis and ascites Article Snippet: PRA and plasma concentrations of aldosterone were measured by specific radioimmunoassays (RIAZEN Renin plasma activity, ZenTech, Belgium; RIA Aldosterone, IMMUNOTECH, Czech Republic, respectively). .. The radioactivity from the radioimmunoassay samples was counted in a Article Title: A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models. Article Snippet: .. Tissues of interest (blood, heart, lungs, spleen, kidneys, muscles, brain, and skin) were removed, weighed and radioactivity was counted in a Article Title: Ferric carboxymaltose is safe and more effective than oral iron for patients with decompensated cirrhosis and iron deficiency anemia, and demonstrates circulatory, renal and prognostic benefits Article Snippet: PRA and plasma concentrations of aldosterone were measured by specific radioimmunoassays (RIAZEN Renin plasma activity, ZenTech, Belgium, and RIA Aldosterone, IMMUNOTECH, Czech Republic, respectively). .. The radioactivity from the radioimmunoassay samples was counted in a Article Title: Impact of small intestinal bacterial overgrowth on systemic inflammation, circulatory and renal function, and liver fibrosis in patients with cirrhosis and ascites Article Snippet: PRA and the plasma concentrations of aldosterone were measured by specific radioimmunoassays (RIAZEN Renin plasma activity, ZenTech, Belgium; and RIA Aldosterone, IMMUNOTECH, Czech Republic, respectively). .. The radioactivity from the radioimmunoassay samples was counted in a Article Title: Comparative effects of hepatocyte growth factor and tacrolimus on acute liver allograft early tolerance Article Snippet: .. Radioactivity was measured with a RIA Assay:Article Title: Impact of overt and subclinical hepatogenous diabetes and metformin treatment on circulatory function, renal function and hemodynamics, inflammatory activity, and prognosis in patients with cirrhosis and ascites Article Snippet: PRA and plasma concentrations of aldosterone were measured by specific radioimmunoassays (RIAZEN Renin plasma activity, ZenTech, Belgium; RIA Aldosterone, IMMUNOTECH, Czech Republic, respectively). .. The radioactivity from the radioimmunoassay samples was counted in a Article Title: Ferric carboxymaltose is safe and more effective than oral iron for patients with decompensated cirrhosis and iron deficiency anemia, and demonstrates circulatory, renal and prognostic benefits Article Snippet: PRA and plasma concentrations of aldosterone were measured by specific radioimmunoassays (RIAZEN Renin plasma activity, ZenTech, Belgium, and RIA Aldosterone, IMMUNOTECH, Czech Republic, respectively). .. The radioactivity from the radioimmunoassay samples was counted in a Article Title: Impact of small intestinal bacterial overgrowth on systemic inflammation, circulatory and renal function, and liver fibrosis in patients with cirrhosis and ascites Article Snippet: PRA and the plasma concentrations of aldosterone were measured by specific radioimmunoassays (RIAZEN Renin plasma activity, ZenTech, Belgium; and RIA Aldosterone, IMMUNOTECH, Czech Republic, respectively). .. The radioactivity from the radioimmunoassay samples was counted in a Muscles:Article Title: A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models. Article Snippet: .. Tissues of interest (blood, heart, lungs, spleen, kidneys, muscles, brain, and skin) were removed, weighed and radioactivity was counted in a |
![A-C. Biodistribution of [ 18 F]MRS-4648 ([ 18 F] 2 ) in C57BL/6 WT mice. A. PET maximum intensity projections of a representative mouse B. Quantification of tracer distribution (n = 3) C. Sum of ex vivo <t>gamma</t> counter experiments (n = 3). D-F. Biodistribution of [ 18 F]PSB-19427 ([ 18 F] 1 ) in C57BL/6 WT mice. D. Maximum intensity projections of a representative mouse. E. Quantification of tracer distribution (n = 3) F. Sum of ex vivo gamma counter experiments after 90 min (n = 3) and 260 min (n = 3).](https://bio-rxiv-images-cdn.bioz.com/dois_ending_with_70/10__1101_slash_2024__11__29__625970/10__1101_slash_2024__11__29__625970___F5.large.jpg)
![A. PET images, CT scans, and merged images of [ 18 F] 2 in the MDA-MB-231 tumor mouse model 90 min after tracer injection. White arrows mark the tumor positions. B. Quantitative PET analysis of [ 18 F] 2 uptake: activity concentration of [ 18 F] 2 in muscle and tumor tissues 90 min after tracer injection (left) and respective tumor-to-muscle ratio (right, n = 5 tumors). C. PET-CT images of [ 18 F] 1 and [ 18 F]FDG in the MDA-MB-231 tumor mouse model, 260 min ([ 18 F] 1 ), or 75 min ([ 18 F]FDG) after injection. From left to right: [ 18 F] 1 without blocker, pretreating with unlabeled compound 1 ( ¶ PSB-19427) or § PSB-12651 10 min before tracer injection, and [ 18 F]FDG. White arrows mark the positions of tumors. D. Quantitative PET analysis of [ 18 F] 1 uptake: activity concentration of [ 18 F] 1 and [ 18 F]FDG in muscle and tumor tissues (left) and tumor-to-muscle ratios (right) after 260 min. [ 18 F]PSB-19427: n = 18 tumors, [ 18 F]PSB-19427 plus PSB-19427 block: n = 8 tumors, [ 18 F]PSB-19427 plus PSB-12651 block: n = 6 tumors, [ 18 F]FDG: n = 18 tumors E. Ex vivo analysis of [ 18 F] 1 uptake as measured by gamma counter: activity concentrations of [ 18 F] 1 in muscle and tumor tissues after 260 min without and with blocking (left) and tumor-to-muscle ratios (right). [ 18 F]PSB-19427: n = 6 tumors, [ 18 F]PSB-19427 plus PSB-19427 block: n = 6 tumors, [ 18 F]PSB-19427 plus PSB-12651 block: n = 5 tumors. # relative to the respective muscle, *relative to [ 18 F] 1 without blocker; <0,05; ** <0,01, ***<0,001, unpaired t-test](https://bio-rxiv-images-cdn.bioz.com/dois_ending_with_70/10__1101_slash_2024__11__29__625970/10__1101_slash_2024__11__29__625970___F6.large.jpg)
![A. PET images, CT scans, and merged images of [ 18 F]PSB-19427 ([ 18 F] 1 ) 260 min after tracer injection. Left: no blocker. Right: Pretreatment with PSB-12651 10 min before tracer injection (§). White arrows mark the positions of tumors. B. Quantitative PET analysis of [ 18 F]PSB-19427 ([ 18 F] 1 ) uptake: activity concentration of [ 18 F] 1 in muscle and tumor tissues after 260 min without and with blocking (§) (left) and tumor-to-muscle ratios (right). [ 18 F]PSB-19427: n = 8 tumors, [ 18 F]PSB-19427 plus PSB-12651 block: n = 8 tumors. C. Ex vivo gamma counter analysis of explanted tissues: activity concentration of [ 18 F] 1 in muscle and tumor tissues after 260 min without and with (§) blocking (left) and tumor-to-muscle ratios (right). [ 18 F]PSB-19427: n = 8 tumors, [ 18 F]PSB-19427 plus PSB-12651 block: n = 8 tumors. # relative to the respective muscle, *relative to [ 18 F] 1 without blocker; <0,05; ** <0,01, ***<0,001, unpaired t-test](https://bio-rxiv-images-cdn.bioz.com/dois_ending_with_70/10__1101_slash_2024__11__29__625970/10__1101_slash_2024__11__29__625970___F7.large.jpg)